Renal ACE2 expression in human kidney disease - PubMed (original) (raw)
. 2004 Dec;204(5):587-93.
doi: 10.1002/path.1670.
Affiliations
- PMID: 15538735
- DOI: 10.1002/path.1670
Renal ACE2 expression in human kidney disease
A T Lely et al. J Pathol. 2004 Dec.
Abstract
Angiotensin-converting enzyme 2 (ACE2) is a recently discovered homologue of angiotensin-converting enzyme (ACE) that is thought to counterbalance ACE. ACE2 cleaves angiotensin I and angiotensin II into the inactive angiotensin 1-9, and the vasodilator and anti-proliferative angiotensin 1-7, respectively. ACE2 is known to be present in human kidney, but no data on renal disease are available to date. Renal biopsies from 58 patients with diverse primary and secondary renal diseases were studied (hypertensive nephropathy n = 5, IgA glomerulopathy n = 8, minimal change nephropathy n = 7, diabetic nephropathy n = 8, focal glomerulosclerosis n = 5, vasculitis n = 7, and membranous glomerulopathy n = 18) in addition to 17 renal transplants and 18 samples from normal renal tissue. Immunohistochemical staining for ACE2 was scored semi-quantitatively. In control kidneys, ACE2 was present in tubular and glomerular epithelium and in vascular smooth muscle cells and the endothelium of interlobular arteries. In all primary and secondary renal diseases, and renal transplants, neo-expression of ACE2 was found in glomerular and peritubular capillary endothelium. There were no differences between the various renal disorders, or between acute and chronic rejection and control transplants. ACE inhibitor treatment did not alter ACE2 expression. In primary and secondary renal disease, and in transplanted kidneys, neo-expression of ACE2 occurs in glomerular and peritubular capillary endothelium. Further studies should elucidate the possible protective mechanisms involved in the de novo expression of ACE2 in renal disease.
Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
- Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Ye M, et al. J Am Soc Nephrol. 2006 Nov;17(11):3067-75. doi: 10.1681/ASN.2006050423. Epub 2006 Oct 4. J Am Soc Nephrol. 2006. PMID: 17021266 - Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy.
Wang G, Lai FM, Lai KB, Chow KM, Kwan CH, Li KT, Szeto CC. Wang G, et al. Am J Nephrol. 2009;29(6):524-31. doi: 10.1159/000185629. Epub 2008 Dec 12. Am J Nephrol. 2009. PMID: 19077419 - Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls.
Mizuiri S, Hemmi H, Arita M, Ohashi Y, Tanaka Y, Miyagi M, Sakai K, Ishikawa Y, Shibuya K, Hase H, Aikawa A. Mizuiri S, et al. Am J Kidney Dis. 2008 Apr;51(4):613-23. doi: 10.1053/j.ajkd.2007.11.022. Epub 2008 Mar 4. Am J Kidney Dis. 2008. PMID: 18371537 - Angiotensin-converting enzyme II in the heart and the kidney.
Danilczyk U, Penninger JM. Danilczyk U, et al. Circ Res. 2006 Mar 3;98(4):463-71. doi: 10.1161/01.RES.0000205761.22353.5f. Circ Res. 2006. PMID: 16514079 Review. - Angiotensin-converting enzyme 2 and the kidney.
Soler MJ, Wysocki J, Batlle D. Soler MJ, et al. Exp Physiol. 2008 May;93(5):549-56. doi: 10.1113/expphysiol.2007.041350. Epub 2008 Jan 25. Exp Physiol. 2008. PMID: 18223023 Review.
Cited by
- SARS-CoV-2 Protein Deposition Enhances Renal Complement Activation and Aggravates Kidney Injury in Membranous Nephropathy After COVID-19.
Wang G, Yang L, Xu X, Guo W, Sun L, Wang Y, Cheng W, Ye N, Kong L, Zhao X, Cheng H. Wang G, et al. Kidney Int Rep. 2024 Aug 10;9(11):3145-3155. doi: 10.1016/j.ekir.2024.08.006. eCollection 2024 Nov. Kidney Int Rep. 2024. PMID: 39534192 Free PMC article. - Kidney damage associated with COVID-19: from the acute to the chronic phase.
Nlandu Y, Tannor EK, Bafemika T, Makulo JR. Nlandu Y, et al. Ren Fail. 2024 Dec;46(1):2316885. doi: 10.1080/0886022X.2024.2316885. Epub 2024 Apr 1. Ren Fail. 2024. PMID: 38561236 Free PMC article. Review. - Acute Kidney Injury: Definition, Management, and Promising Therapeutic Target.
Almazmomi MA, Esmat A, Naeem A. Almazmomi MA, et al. Cureus. 2023 Dec 28;15(12):e51228. doi: 10.7759/cureus.51228. eCollection 2023 Dec. Cureus. 2023. PMID: 38283512 Free PMC article. Review. - Studying the Roles of the Renin-Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model.
Chen CY, Lin MW, Xie XY, Lin CH, Yang CW, Wu PC, Liu DH, Wu CJ, Lin CS. Chen CY, et al. Int J Mol Sci. 2023 Dec 26;25(1):329. doi: 10.3390/ijms25010329. Int J Mol Sci. 2023. PMID: 38203500 Free PMC article. - The RAAS Goodfellas in Cardiovascular System.
Caputo I, Bertoldi G, Driussi G, Cacciapuoti M, Calò LA. Caputo I, et al. J Clin Med. 2023 Oct 31;12(21):6873. doi: 10.3390/jcm12216873. J Clin Med. 2023. PMID: 37959338 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous